# Using quality-adjusted progression-free survival as an outcome measure to assess the benefits of cancer drugs in randomized-controlled trials: case of the BOLERO-2 trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/using-quality-adjusted-progression-free-survival-as-an-outcome-measure-to-assess/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Vakaramoko Diaby,Georges Adunlin,Askal Ayalew Ali,Rima Tawk |
| Citations | 16 |
| DOI | 10.1007/s10549-014-3047-y |
| Fields | Economics, Econometrics and Finance,Mathematics |
| Open Access | true |
| OA Status | green |
| OA URL | https://www.ncbi.nlm.nih.gov/pmc/articles/4461432 |
| OpenAlex ID | https://openalex.org/W2074057249 |
| PMID | 25017612 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Askal Ayalew Ali](https://scholariq.org/researchers/askal-ayalew-ali/)
- [Rima Tawk](https://scholariq.org/researchers/rima-tawk/)

## Paper journal

- [Breast Cancer Research and Treatment](https://scholariq.org/journals/breast-cancer-research-and-treatment/)

## Paper primary topic

- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)

## Paper topics

- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Statistical Methods in Clinical Trials](https://scholariq.org/topics/statistical-methods-in-clinical-trials/)
- [Economic and Financial Impacts of Cancer](https://scholariq.org/topics/economic-and-financial-impacts-of-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.